Clin Exp Rheumatol
-
Multicenter Study
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.
To evaluate the efficacy of rituximab in central nervous system (CNS) manifestations of patients with primary Sjögren's syndrome (pSS). ⋯ Rituximab does not seem to be effective in progressive multiple sclerosis-like manifestations of patients with pSS-related CNS involvement.